• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Eisai is a great c....ompany

Anonymous

Guest
Eisai is a great company...just managed poorly from the CEO down to the District sales managers. Not everyone but I would say 70% which puts in my mind the "bad apple" analogy. Good luck to everyone that chooses to stay. I am out!